At Epiodyne, our mission is to improve the lives of patients, families, and communities by bringing to market new products to treat neurobehavioral symptoms of brain disorders.
A Growing Crisis
The emotional and economic cost of brain disorders in the US is high and growing. We believe there is a major unmet need to alleviate the heavy burden created by emotional and behavioral symptoms of these disorders. New, effective treatments are needed.
Americans suffering from serious mental illness1
Percentage of patients with obsessive compulsive disorder do not respond to available treatments2
Americans living with opioid use disorder3
The projected number of Americans living with Alzheimer’s disease by the year 20504